Danish pharmaceutical giant Novo Nordisk on Tuesday said it has followed “smart Indian pricing,” which is lower than prices in many countries, to make its blockbuster weight-loss drug Wegovy ...

Shares of Novo Nordisk (NYSE: NVO) are tumbling on Monday, down 5.6% as of 2:11 p.m. ET. The drop comes as the S&P 500 (SNPINDEX: ^GSPC) and the Nasdaq Composite (NASDAQINDEX: ^IXIC) both jumped 0 ...

The Swissotel in Sarajevo, Bosnia. (Google Maps) JTA — A meeting of leading European rabbis has been canceled in Sarajevo after high-profile appeals against their gathering.

Deep Apple discovers drug candidates using its AI-based platform that screens virtual libraries of billions of compounds to cut drug discovery time, the company said. Under the deal, Novo will ...

Novo Nordisk's Q1 showed robust sales/EPS growth, fueled by soaring GLP-1 demand in a multi-billion dollar market. Read why I reiterate buy rating on NVO stock.

Novo Nordisk launches new late-stage trial for next-gen weight loss drug CagriSema Jun. 10, 2025 12:11 PM ET Novo Nordisk A/S (NVO) Stock, NONOF Stock By: Dulan Lokuwithana, SA News Editor 7 Comments ...

Novo Nordisk (NVO -1.00%) stock, maker of the blockbuster GLP-1 agonist weight-loss drugs Ozempic and Wegovy, jumped a lucky 7% through 12:20 p.m. ET Tuesday after London's Financial Times ...

Parvus Asset Management, known for its previous involvements with Ryanair and Flutter Entertainment, aims to influence the selection of Novo Nordisk’s new CEO, FT reported, citing sources ...

Activist hedge fund Parvus Asset Management is building a stake in Ozempic-maker Novo Nordisk as the drugmaker hunts for a new chief executive following a share price slump. The London-based hedge ...

Overview NVO Novo Nordisk AS $69.15 -0.96 % Regeneron Pharmaceuticals, Inc. REGN ...

In one respect at least, Sarajevo has been lucky. Left untreated, leptospirosis can be deadly, with a mortality rate of more than 50% for people who suffer from severe bleeding of the lungs.